Post Profile






Spectral Medical's sepsis treatment fails late-stage study

(Reuters) - Spectral Medical Inc said its experimental treatment for sepsis - a common, oft-deadly complication of infection - failed a late-stage study, stymieing the company's plans to bring to market the first FDA-approved device for the condition.
read more

share

Related Posts


Ivera Gets FDA 510(k) Clearance To Market Curos™ Port Protector, Medical Device Which Lowers Hospital Acquired Bloodstream Infection Exposure

Health : Medical News Today

Ivera Medical Corporation, a San Diego (CA) based medical device company today announced that it received FDA 510(k) clearance to begin marketing its Curos™ Port Protector, an innovative medical device that decontaminates needleless...

SafeStitch Medical, Inc. Announces FDA Approval To Market Its SMART DilatorTM

Health : Medical News Today

SafeStitch Medical, Inc. (OTCBB:SFES) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's 510(k) application to begin U.S. marketing of its SMART DilatorTM, the first esophageal dilator to indicat...

Cancer Treatment Developed at UK Approved for Clinical Trials

Health : Newswise Medical News

An investigational medical device for the treatment of late stage lung cancer, pioneered by researchers at University of Kentucky, has been approved for clinical trials by the Food and Drug Administration (FDA). UK is the only site ...

St. Jude Medical Receives FDA Approval For Expansion Of BROADEN Deep Brain Stimulation Study For Depression

Health : Medical News Today

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for expansion of its BROADEN™ (BROdmann Area 25 DEep brain Neurostimulation) s...

Wright Medical Group, Inc. Receives FDA Approval To Market CONSERVE(R) Plus Total Hip Resurfacing System

Health : Medical News Today

Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, announced that the United States Food and Drug Administration (FDA) has given approval to the Company to market its original CONSERVE® Plus Tota...

Comments


Copyright © 2016 Regator, LLC